Update in trauma anesthesiology: Perioperative resuscitation management

Anesthesia and Analgesia

Volumn 115, Issue 6, 2012, Pages 1326-1333

  Tobin, Joshua M ^a   Varon, Albert J ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BICARBONATE; FRESH FROZEN PLASMA; HYDROCORTISONE; PHENYLEPHRINE; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; VASOPRESSIN; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT RESPIRATORY DISTRESS SYNDROME; ANESTHESIOLOGY; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; DRUG MEGADOSE; EMERGENCY HEALTH SERVICE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEMORRHAGIC SHOCK; HUMAN; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; LOADING DRUG DOSE; LOW DRUG DOSE; MILITARY SERVICE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; REVIEW; TRAUMATIC BRAIN INJURY; ANESTHESIA; BLOOD TRANSFUSION; INDUCED HYPOTENSION; INJURY; METHODOLOGY; SOLDIER; UTILIZATION REVIEW;

ANESTHESIA; ANESTHESIOLOGY; ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; FACTOR VIIA; HUMANS; HYPOTENSION, CONTROLLED; MILITARY PERSONNEL; PERIOPERATIVE CARE; RECOMBINANT PROTEINS; RESUSCITATION; TRANEXAMIC ACID; TRAUMA CENTERS; VASOCONSTRICTOR AGENTS; VASOPRESSINS; WOUNDS AND INJURIES;

EID: 84870236690     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3182639f20     Document Type: Review

References (73)

1. Lerner EB, Moscati RM. The golden hour: scientifc fact or medical "urban legend"? Acad Emerg Med 2001;8:758-60
2. Santy P. Shock tramatique dans les blessures de guerre, analysis d'observations. Bull Med Soc Chir 1918;44:205
3. Cudnik MT, Nwgard CD, Sayre MR, Steinberg SM. Level I versus level II trauma centers: an outcomes-based assessment. J Trauma 2009;66:1321-6
4. Sampalis JS, Denis R, Frechette P, Brown R, Fleiszer D, Mulder D. Direct transport to tertiary trauma centers versus transfer from lower level facilities: impact on mortality and morbidity among patients with major trauma. J Trauma 1997;43:288-95
5. Butler FK Jr, Hagmann J, Butler EG. Tactical combat casualty care in special operations. Mil Med 1996;161:3-16
6. Johannigman JA. Maintaining the continuum of en route care. Crit Care Med 2008;36:S377-82
7. Grissom TE, Farmer JC. The provision of sophisticated critical care beyond the hospital: lessons from physiology and military experiences that apply to civil disaster medical response. Crit Care Med 2005;33:S13-21
8. Davis PR, Rickards AC, Ollerton JE. Determining the composition and benefit of the pre-hospital medical response team in the conflict setting. J R Army Med Corps 2007;153:269-73
9. Tobin JM, Via DK, Carter T. Tactical evacuation: extending critical care on rotary wing platforms to forward surgical facilities. Mil Med 2011;176:4-6
10. Bickey NW, Jenkins D, Butler FK. Tactical Evacuation Care Improvements Within the Department of Defense 2011-03. Proceedings of Defense Health Board. Available at: http://www.health.mil/dhb/recommendations.cfm. Accessed March 11, 2012
11. Lee JC, Peitzman AB. Damage-control laparotomy. Curr Opin Crit Care 2006;12:346-50
12. Duchesne JC, Kimonis K, Marr AB, Rennie KV, Wahl G, Wells JE, Islam TM, Meade P, Stuke L, Barbeau JM, Hunt JP, Baker CC, McSwain NE Jr. Damage control resuscitation in combination with damage control laparotomy: a survival advantage. J Trauma 2010;69:46-52
13. Duchesne JC, McSwain NE Jr, Cotton BA, Hunt JP, Dellavolpe J, Lafaro K, Marr AB, Gonzalez EA, Phelan HA, Bilski T, Greiffenstein P, Barbeau JM, Rennie K V, Baker CC, Brohi K, Jenkins DH, Rotondo M. Damage control resuscitation: the new face of damage control. J Trauma 2010;69:976-90
14. Tuttle MS, Smith WR, Williams AE, Agudelo JF, Hartshorn CJ, Moore EE, Morgan SJ. Safety and effcacy of damage control external fxation versus early defnitive stabilization for femoral shaft fractures in the multiple-injured patient. J Trauma 2009;67:602-5
15. Pape HC, Tornetta P III, Tarkin I, Tzioupis C, Sabeson V, Olson SA. Timing of fracture fxation in multitrauma patients: the role of early total care and damage control surgery. J Am Acad Orthop Surg 2009;17:541-9
16. Rosenfeld JV. Damage control neurosurgery. Injury 2004;35:655-60
17. Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D'Urso P, Kossmann T, Ponsford J, Seppelt I, Reilly P, Wolfe R. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med 2011;364:1493-502
18. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, Flaherty SF, Grathwohl KW, Spinella PC, Perkins JG, Beekley AC, McMullin NR, Park MS, Gonzalez EA, Wade CE, Dubick MA, Schwab CW, Moore FA, Champion HR, Hoyt DB, Hess Jr. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007;62:307-10
19. Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fuid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105-9
20. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002;52:1141-6
21. Morrison CA, Carrick MM, Norman MA, Scott BG, Welsh FJ, Tsai P, Liscum KR, Wall MJ Jr, Mattox KL. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemor-rhagic shock: preliminary results of a randomized controlled trial. J Trauma 2011;70:652-63
22. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specifc blood products to treat the coagulopathy of trauma. Transfusion 2006;46:685-6
23. Gunter OL Jr, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008;65:527-34
24. Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess Jr. Blood transfusion rates in the care of acute trauma. Transfusion 2004;44:809-13
25. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006;60:S91-6
26. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63:805-13
27. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008;248:447-58
28. Snyder CW, Weinberg JA, McGwin G Jr, Melton SM, George RL, Reiff DA, Cross JM, Hubbard-Brown J, Rue LW III, Kerby JD. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 2009; 66:358-62
29. Magnotti LJ, Zarzaur BL, Fischer PE, Williams RF, Myers AL, Bradburn EH, Fabian TC, Croce MA. Improved survival after hemostatic resuscitation: does the emperor have no clothes? J Trauma 2011;70:97-102
30. Davenport R, Curry N, Manson J, De'Ath H, Coates A, Rourke C, Pearse R, Stanworth S, Brohi K. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma 2011;70:90-5
31. De Biasi AR, Stansbury SL, Dutton RP, Stein DM, Scalea TM, Hess Jr. Blood product use in trauma resuscitation: plasma defcit versus plasma ratio as predictors of mortality in trauma. Transfusion 2011;51:1925-32
32. Ho AM, Dion PW, Yeung JH, Holcomb JB, Critchley LA, Ng CS, Karmakar MK, Cheung CW, Rainer TH. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology 2012;116:716-28
33. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with signifcant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23-32
34. CRASH-2 Collaborators, Intracranial Bleeding Study. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ 2011;343:d3795
35. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012;147:113-9
36. Knudson MM, Cohen MJ, Reidy R, Jaeger S, Bacchetti P, Jin C, Wade CE, Holcomb JB. Trauma, transfusions, and use of recombinant factor VIIa: a multicenter case registry report of 380 patients from the Western Trauma Association. J Am Coll Surg 2011;212:87-95
37. Dutton RP, McCunn M, Hyder M, D'Angelo M, O'Connor J, Hess JR, Scalea TM. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004;57:709-18
38. Spinella PC, Perkins JG, McLaughlin DF, Niles SE, Grathwohl KW, Beekley AC, Salinas J, Mehta S, Wade CE, Holcomb JB. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma 2008;64:286-93
39. Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005;59:8-15
40. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B. Results of the CONTROL trial: eff-cacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010;69:489-500
41. Raab H, Lindner KH, Wenzel V. Preventing cardiac arrest during hemorrhagic shock with vasopressin. Crit Care Med 2008;36:S474-80
42. Robin JK, Oliver JA, Landry DW. Vasopressin defciency in the syndrome of irreversible shock. J Trauma 2003;54:S149-54
43. Krismer AC, Dunser MW, Lindner KH, Stadlbauer KH, Mayr VD, Lienhart HG, Arntz RH, Wenzel V. Vasopressin during car-diopulmonary resuscitation and different shock states: a review of the literature. Am J Cardiovasc Drugs 2006;6:51-68
44. Raedler C, Voelckel WG, Wenzel V, Krismer AC, Schmittinger CA, Herff H, Mayr VD, Stadlbauer KH, Lindner KH, Konigsrainer A. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fuid resuscitation versus improved outcome after vasopressin. Anesth Analg 2004;98:1759-66
45. Voelckel WG, Raedler C, Wenzel V, Lindner KH, Krismer AC, Schmittinger CA, Herff H, Rheinberger K, Konigsrainer A. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med 2003;31:1160-5
46. Morales D, Madigan J, Cullinane S, Chen J, Heath M, Oz M, Oliver JA, Landry DW. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999;100:226-9
47. Krismer AC, Wenzel V, Voelckel WG, Innerhofer P, Stadlbauer KH, Haas T, Pavlic M, Sparr HJ, Lindner KH, Koenigsrainer A. Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock: three cases and a brief analysis of the literature. Anaesthesist 2005;54:220-4
48. Sharma RM, Setlur R. Vasopressin in hemorrhagic shock. Anesth Analg 2005;101:833-4
49. Tsuneyoshi I, Onomoto M, Yonetani A, Kanmura Y. Low-dose vasopressin infusion in patients with severe vasodilatory hypotension after prolonged hemorrhage during general anesthesia. J Anesth 2005;19:170-3
50. Rajani RR, Ball CG, Feliciano DV, Vercruysse GA. Vasopressin in hemorrhagic shock: review article. Am Surg 2009;75:1207-12
51. Stadlbauer KH, Wenzel V, Krismer AC, Voelckel WG, Lindner KH. Vasopressin during uncontrolled hemorrhagic shock: less bleeding below the diaphragm, more perfusion above. Anesth Analg 2005;101:830-2
52. Lienhart HG, Wenzel V, Braun J, Dorges V, Dunser M, Gries A, Hasibeder WR, Helm M, Lefering R, Schlechtriemen T, Trimmel H, Ulmer H, Ummenhofer W, Voelckel WG, Waydhas C, Lindner K. Vasopressin for therapy of persistent traumatic hemorrhagic shock: the VITRIS.at study [in German]. Anaesthesist 2007;56:145-8
53. Lienhart HG, Lindner KH, Wenzel V. Developing alternative strategies for the treatment of traumatic haemorrhagic shock. Curr Opin Crit Care 2008;14:247-53
54. Cooper MS, Stewart PM. Corticosteroid insuffciency in acutely ill patients. N Engl J Med 2003;348:727-34
55. Burchard K. A review of the adrenal cortex and severe infamma-tion: quest of the "eucorticoid" state. J Trauma 2001;51:800-14
56. Hoen S, Asehnoune K, Brailly-Tabard S, Mazoit JX, Benhamou D, Moine P, Edouard AR. Cortisol response to corticotropin stimulation in trauma patients: infuence of hemorrhagic shock. Anesthesiology 2002;97:807-13
57. Hoen S, Mazoit JX, Asehnoune K, Brailly-Tabard S, Benhamou D, Moine P, Edouard AR. Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med 2005;33:2737-43
58. Payen JF, Dupuis C, Trouve-Buisson T, Vinclair M, Broux C, Bouzat P, Genty C, Monneret D, Faure P, Chabre O, Bosson JL. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med 2012;40:29-35
59. Ho KM, Leonard AD. Concentration-dependent effect of hypo-calcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study. Anaesth Intensive Care 2011;39:46-54
60. Sonett J, Pagani FD, Baker LS, Honeyman T, Hsi C, Knox M, Cronin C, Landow L, Visner MS. Correction of intramyocar-dial hypercarbic acidosis with sodium bicarbonate. Circ Shock 1994;42:163-73
61. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000;117:260-7
62. Boyd JH, Walley KR. Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Curr Opin Crit Care 2008;14:379-83
63. Martini WZ, Dubick MA, Pusateri AE, Park MS, Ryan KL, Holcomb JB. Does bicarbonate correct coagulation function impaired by acidosis in swine? J Trauma 2006;61:99-106
64. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8
65. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guerin C, Prat G, Morange S, Roch A. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:1107-16
66. Butkus DE. Post-traumatic acute renal failure in combat casualties: a historical review. Mil Med 1984;149:117-24
67. Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest 2003;123:1266-75
68. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77
69. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56
70. Tisherman SA. Suspended animation for resuscitation from exsanguinating hemorrhage. Crit Care Med 2004;32:S46-50
71. Behringer W, Safar P, Wu X, Kentner R, Radovsky A, Kochanek PM, Dixon CE, Tisherman SA. Survival without brain damage after clinical death of 60-120 mins in dogs using suspended animation by profound hypothermia. Crit Care Med 2003;31:1523-31
72. Finkelstein RA, Alam HB. Induced hypothermia for trauma: current research and practice. J Intensive Care Med 2010;25:205-26
73. Dietrich WD, Cappuccino A, Cappuccino H. Systemic hypothermia for the treatment of acute cervical spinal cord injury in sports. Curr Sports Med Rep 2011;10:50-4